Skip to main content
Premium Trial:

Request an Annual Quote

Base4 Drops Bioinformatics From Name, Expands Reach

Premium

TORONTO--Base4 Bioinfor-matics said it is dropping the word bioinformatics from its name to reflect its significantly expanded strategy, beyond providing bioinformatics services. The company's broader mission includes selling its knowledge-management enterprise software package for pharmaceutical research and development.

Martin Sumner-Smith, Base4's president and CEO, said the company got its start "by offering products and services to manage the flood of biological information coming from gene analysis." Now, he said, the company serves general information needs of pharmaceutical discovery and development. "Base4 is now a general pharmaceutical informatics company."

Base4 claimed that there are nearly 1,000 users of its flagship product PharMatrix.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.